{
  "resourceType" : "Procedure",
  "id" : "Fall13-Systemtherapie-EC-Pac-H",
  "meta" : {
    "profile" : ["https://www.senologie.org/fhir/StructureDefinition/senologie-systemtherapie-procedure"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Procedure Fall13-Systemtherapie-EC-Pac-H</b></p><a name=\"Fall13-Systemtherapie-EC-Pac-H\"> </a><a name=\"hcFall13-Systemtherapie-EC-Pac-H\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-senologie-systemtherapie-procedure.html\">BIH Senologie Systemtherapie (übergeordnet)</a></p></div><p><b>MII EX Onko Systemische Therapie Intention</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention K}\">kurativ</span></p><p><b>status</b>: Completed</p><p><b>category</b>: <span title=\"Codes:{http://snomed.info/sct 18629005}\">Administration of medication</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 385786002}\">Adjuvante Chemotherapie EC-Pac-H</span></p><p><b>subject</b>: <a href=\"Patient-Fall13-Patient-Margarete-Schreiber.html\">Margarete Schreiber  Female, DoB: 1960-08-22 ( http://fhir.bih-charite.de/sid/patient-id#SENO-2025-013)</a></p><p><b>performed</b>: 2025-05-05 --&gt; 2025-11-15</p><p><b>reasonReference</b>: </p><ul><li><a href=\"Condition-Fall13-Diagnose-Rechts.html\">Condition Malignant neoplasm of breast</a></li><li><a href=\"Condition-Fall13-Diagnose-Links.html\">Condition Malignant neoplasm of breast</a></li></ul><p><b>outcome</b>: <span title=\"Codes:\">Abgeschlossen, gut vertragen</span></p><p><b>note</b>: </p><blockquote><div><p>4x EC q3w, gefolgt von 12x Paclitaxel weekly + Trastuzumab q3w (18 Zyklen gesamt). Indikation primär HER2+ rechts, Chemotherapie wirkt auf beide Seiten.</p>\n</div></blockquote></div>"
  },
  "extension" : [{
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-intention",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention",
        "code" : "K",
        "display" : "kurativ"
      }]
    }
  }],
  "status" : "completed",
  "category" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "18629005",
      "display" : "Administration of medication"
    }]
  },
  "code" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "385786002",
      "display" : "Chemotherapy care (regime/therapy)"
    }],
    "text" : "Adjuvante Chemotherapie EC-Pac-H"
  },
  "subject" : {
    "reference" : "Patient/Fall13-Patient-Margarete-Schreiber"
  },
  "performedPeriod" : {
    "start" : "2025-05-05",
    "end" : "2025-11-15"
  },
  "reasonReference" : [{
    "reference" : "Condition/Fall13-Diagnose-Rechts"
  },
  {
    "reference" : "Condition/Fall13-Diagnose-Links"
  }],
  "outcome" : {
    "text" : "Abgeschlossen, gut vertragen"
  },
  "note" : [{
    "text" : "4x EC q3w, gefolgt von 12x Paclitaxel weekly + Trastuzumab q3w (18 Zyklen gesamt). Indikation primär HER2+ rechts, Chemotherapie wirkt auf beide Seiten."
  }]
}